$740 Million is the total value of Rhenman & Partners Asset Management AB's 95 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACAD | New | Acadia Pharmaceuticals Inc | $10,204,000 | – | 338,882 | +100.0% | 1.38% | – |
| FLXN | New | Flexion Therapeutics Inc | $6,553,000 | – | 261,686 | +100.0% | 0.88% | – |
| PBYI | New | Puma Biotechnology Inc | $4,943,000 | – | 50,000 | +100.0% | 0.67% | – |
| SGMO | New | Sangamo Therapeutics Inc Reg | $4,195,000 | – | 255,793 | +100.0% | 0.57% | – |
| ONCE | New | Spark Therapeutics Inc | $3,610,000 | – | 70,200 | +100.0% | 0.49% | – |
| VRAY | New | ViewRay Inc Reg | $2,615,000 | – | 282,385 | +100.0% | 0.35% | – |
| ZGNX | New | Zogenix Inc Reg | $2,075,000 | – | 51,808 | +100.0% | 0.28% | – |
| SNSS | New | Sunesis Pharmaceuticals Inc Reg | $1,661,000 | – | 450,100 | +100.0% | 0.22% | – |
| TTPH | New | Tetraphase Pharmaceuticals Inc | $1,014,000 | – | 160,908 | +100.0% | 0.14% | – |
| JHG | New | Janus Henderson Group Plc Reg | $456,000 | – | 11,906 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-01-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.